FDA Inspection 677264 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1670014

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on August 27, 2010 in Houston, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 27, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Citations

IDCFRDescription
16721 CFR 606.170(b)Adverse reaction - fatality